Alison Baird, MD, PhD, FRACP
Professor of Neurology and Vice-Chair for Mentoring, Professor of Physiology/Pharmacology
Medical Director, SUNY Downstate Stroke Center
Director, Division of Cerebrovascular Disease and Stroke
Dr. Baird is Professor of Neurology and Physiology/Pharmacology and Vice-Chair for Mentoring in the Department of Neurology. Throughout her career, Dr. Baird has combined clinical and translational stroke research with clinical practice. Her research has focused on advanced neuroimaging techniques to study the mechanisms and predictors of tissue and clinical recovery after stroke. She has since expanded her studies of neuroimaging markers to blood-based biomarkers, using cellular and molecular profiling of the peripheral blood, to develop clinical and genomic markers for early stroke detection.
Dr. Baird joined Downstate in 2007 as the Director of the Stroke Program and Professor of Neurology and Physiology/Pharmacology. She came from the National Institutes of Health in Bethesda, MD where she was chief of the Stroke Neuroscience Unit and Principal Investigator at the National Institute of Neurological Disorders and Stroke.
A Fellow of the Royal Australasian College of Physicians, Dr. Baird received her medical degree from the University of Melbourne, Australia, and a Master of Public Health from Harvard. After completing a Clinical Stroke Fellowship at Beth Israel Deaconess Medical Center and Harvard University in Boston, she joined the Neurology faculty at Harvard Medical School.
Dr. Baird lectures worldwide and has published over 110 peer-reviewed original journal articles, editorials, review articles and book chapters. She has performed extensive clinical and translational research and holds a number of patent applications. She serves on the editorial boards of a number of medical journals.
Dr. Baird is recognized as one of America's Best Doctors®. Dr. Baird is a Fellow of the American Heart Association/American Stroke Association, the Royal Australasian College of Physicians and the European Stroke Council and a member of the American Academy of Neurology, the American Neurological Association, the New York State Neurological Society, the Society for Neuroscience, the Australian Association of Neurologists and the Stroke Society of Australasia.
Academic Qualifications:
- MB, BS: University of Melbourne, Victoria, Australia
- Fellowship: Fellowship of the Royal Australasian College of Physicians (completion of post-graduate specialist training in neurology and internal medicine)
- Clinical Fellowship: Cerebrovascular Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA
- PhD: University of Melbourne
- MPH: Harvard School of Public Health
Clinical Subspecialty:
- Stroke
- Cerebrovascular Disease
Research interests:
- Neuroimaging of Stroke
- Clinical Trials
- Gene Expression Profiling
Patient Appointments:
Thursday afternoons.
- Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ; American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007 Jun 5;115(22):2878-901. Epub 2007 May 21. PMID: 17515457
- Baird AE. Blood genomics in human stroke. Stroke. 2007 Feb;38(2 Suppl):694-8. Review.
- Baird AE. Blood biologic markers of stroke: improved management, reduced cost? Curr Atheroscler Rep.2006 Jul;8(4):267-75. Review. PMID: 16822391
- Simak J, Gelderman MP, Yu H, Wright V, Baird AE. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost. 2006 Jun;4(6):1296-302. PMID: 16706974
- Baird AE. The forgotten lymphocyte: immunity and stroke. Circulation. 2006 May 2;113(17):2035-6. No abstract available. PMID: 16651483
- Baird AE. The blood option: transcriptional profiling in clinical trials. Pharmacogenomics. 2006 Mar;7(2):141-4. PMID: 16515391
- Wright VL, Olan W, Dick B, Yu H, Alberts-Grill N, Latour LL, Baird AE. Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease. Neurology. 2005 Jul 12;65(1):27-32. PMID: 16009882
- Moore DF, Li H, Jeffries N, Wright V, Cooper RA Jr, Elkahloun A, Gelderman MP, Zudaire E, Blevins G, Yu H, Goldin E, Baird AE. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005 Jan 18;111(2):212-21. Epub 2005 Jan 3. PMID: 15630028
- Nadareishvili ZG, Li H, Wright V, Maric D, Warach S, Hallenbeck JM, Dambrosia J, Barker JL, Baird AE. Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology. 2004 Oct 26;63(8):1446-51. PMID: 15505163